Navigation Links
Invitae to announce fourth quarter and year-end 2016 financial results and 2017 guidance and will host conference call on February 13, 2017
Date:1/30/2017

SAN FRANCISCO, Jan. 30, 2017 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that it will report its fourth quarter and year-end 2016 financial results and provide 2017 guidance on Monday, February 13, 2017, and Invitae's management team will host a conference call that day at 4:45 p.m. Eastern / 1:45 p.m. Pacific.

During the call, Invitae's management team will briefly review financial results, guidance, and recent developments and will spend the majority of the call fielding questions from analysts and investors. Management also invites investors to submit questions to ir@invitae.com at any time leading up to or during the call. The dial-in numbers for the conference call are (877) 201-0168 for domestic callers and (647) 788-4901 for international callers, and the reservation number for both is 60742797.

Additionally, Invitae announced that it will present at the Leerink Partners 6th Annual Global Healthcare Conference on Wednesday, February 15, 2017 at 1:00 p.m. Eastern / 10:00 a.m. Pacific.

The live, listen-only webcasts of both the conference call and the presentation at Leerink may be accessed by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcasts will be available shortly after the conclusions of the call and presentation and will be archived on the company's website.

About Invitae

Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae's goal is to aggregate most of the world's genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company currently provides a diagnostic service comprising hundreds of genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. Additionally, the company has created a Genome Network to connect patients, clinicians, advocacy organizations, researchers, and drug developers to accelerate the understanding, diagnosis, and treatment of hereditary disease. For more information, visit our website at invitae.com.

Contact:
Laura D'Angelo
pr@invitae.com
314-920-0617

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/invitae-to-announce-fourth-quarter-and-year-end-2016-financial-results-and-2017-guidance-and-will-host-conference-call-on-february-13-2017-300398522.html


'/>"/>
SOURCE Invitae Corporation
Copyright©2017 PR Newswire.
All rights reserved


Related biology news :

1. Merck Animal Health announces Vetsulin
2. AAPS announces 2013 National Biotechnology Conference award winners
3. PLOS announces Accelerating Science Award Program
4. MARC travel awards announced for the 2013 60th Annual ACSM Meeting & 4th World Congress
5. DFG announces recipients of 2013 Heinz Maier-Leibnitz Prize
6. Missouri Botanical Garden program announces collaboration with LHerboretum
7. Scripps Research announces research & license agreement with Janssen Pharmaceuticals
8. TGen and Riddell announce partnership for biomarker study of concussive injuries
9. MARC Travel Awards announced for the SDB 2013 72nd Annual Meeting
10. MARC Travel Awards announced for the ENDO 2013 95th Annual Meeting
11. Program announced for the 4th Asia-Pacific Osteoporosis Meeting in Hong Kong
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Md. , March 23, 2017  Northwest ... developing DCVax® personalized immune therapies for solid tumor ... the $7.5 million financing it announced last Friday, ... sold to several institutional investors securities totaling 28,843,692 ... per share, and 10,000,000 shares of Class C ...
(Date:3/23/2017)... Branford, CT (PRWEB) , ... March 23, 2017 ... ... Counsel, LLC, was recently selected by the Connecticut Technology Council (CTC) as a ... honored at CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company ... A financing and note conversion to commercialize its Cool ... is focused on developing products that are simultaneously profitable ... million in the last 18 months. This latest round ... Bridge Venture Partners. The company,s primary ...
(Date:3/22/2017)... ... 2017 , ... Researchers face a fundamental challenge as they ... tissues, bones, even whole organs to implant in people to treat disease or ... the developing tissue. , Current bioengineering techniques, including 3-D printing, can’t fabricate ...
Breaking Biology Technology: